Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs dexmedetomidine vs nitroglycerin for controlled hypotension during FESS
PACTR202202877370804Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of propofol, dexmedetomidine and nitroglycerin in None (3 arms), sponsored by Ain Shams University. Primary endpoints: Efficacy in inducing controlled hypotension and Time to target blood pressure. Started Aug 2019; status: completed.
02
Drugs
propofoldexmedetomidinenitroglycerin
Beyond the preview
Go deeper on PACTR202202877370804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202202877370804.